United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for PSYCHEMEDICS CORP? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -31.54% | -84.34% | -172.51% | -449.18% | -870.23% | -955.52% |
|---|---|---|---|---|---|---|
| ROA | -18.03% | -37.65% | -35.89% | -43.5% | -48.68% | -47.78% |
| Gross Margin | 36.07% | 32.07% | 30.63% | 29.77% | 28.03% | 28.19% |
| Net Margin | -9.45% | -14.35% | -13.53% | -15.75% | -17.63% | -17.28% |
| Total Assets | $8,318.00K | $8,920.08K | $9,575.33K | $10,288.49K | $11,064.76K | $11,909.79K |
| Net Income | -$1,861.00K | -$3,245.11K | -$3,318.63K | -$4,320.58K | -$5,197.38K | -$5,488.17K |